CAREU
DEAD

Serial Number

87759086

Owner

Medisensor, Inc.

Attorney

Sung Joo

First Use Date

Jul 4, 2017

Filing Date

Jan 17, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CAREU Trademark

Serial Number: 87759086 • Registration: 5603219

CAREU is a trademark filed by Medisensor, Inc. on January 17, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

Medisensor, Inc. (11 trademarks)

1231 Daegu Convergence R&D Center
Daegu 704-948 , KR

Entity Type: 03

Trademark Details

Filing Date

January 17, 2018

Registration Date

November 6, 2018

First Use Anywhere

July 4, 2017

First Use in Commerce

October 25, 2017

Published for Opposition

June 12, 2018

Cancellation Date

May 16, 2025

Goods & Services

Computer software and computer hardware for evaluation, verification and administration of medical data for medical and diagnostic purposes in the field of Immunodeficiencies, Immune disorders, Inflammatory disorders, Oncological disorders, Infectious diseases, Genetic diseases, Metabolic diseases, Rare diseases, Immune assay, Molecular diagnostics, Nervous system disorders, Cardiovascular disorders, Respiratory disorders, Musculoskeletal disorders, Genitourinary disorders, Endocrinological disorders, Digestive disorders, Nephrological diseases, Ocular diseases, Hemopathy, Skin diseases, Eye diseases, diabetes, malaria and fertility and for use in conjunction with blood glucose monitoring devices and HbA1c monitoring devices; Computer software and computer hardware for linking medical instruments and devices

Diagnostic test kits, for clinical and medical laboratory use, comprised of medical diagnostic preparations and diagnostic test strips for use in the field of Immunodeficiencies, Immune disorders, Inflammatory disorders, Oncological disorders, Genetic diseases, Metabolic diseases, Rare diseases, Immune assay, Molecular diagnostics, Nervous system disorders, Respiratory disorders, Musculoskeletal disorders, Genitourinary disorders, Endocrinological disorders, Digestive disorders, Nephrological diseases, Ocular diseases, Hemopathy, Skin diseases, Eye diseases, diabetes and malaria and for use with blood glucose monitoring devices and HbA1c monitoring devices

Filing History

CANCELLED SEC. 8 (6-YR)
May 16, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 6, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 6, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 2, 2018 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 1, 2018 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 12, 2018 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 12, 2018 AITU
USE AMENDMENT FILED
Aug 16, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 16, 2018 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 7, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 12, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jun 12, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 23, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 10, 2018 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 9, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
May 8, 2018 XAEC
ASSIGNED TO LIE
May 8, 2018 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 8, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
May 8, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 8, 2018 CNEA
ASSIGNED TO EXAMINER
Apr 26, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2018 NWOS
NEW APPLICATION ENTERED
Jan 20, 2018 NWAP